Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 9/20 | 0.53 |
| ▸ | CNR1 | P21554 | 7/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.53 |
| ▸ | PPARA | Q07869 | 3/20 | 0.48 |
| ▸ | PPARG | P37231 | 2/20 | 0.47 |
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.39 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8345725 | 1.00 | CNR2 (0.53) | CNR2CNR1TRPA1TRPV1PPARA | |
| SCHEMBL3306709 | 1.00 | CNR2 (0.53) | CNR2CNR1TRPA1TRPV1PPARA | |
| SCHEMBL17540809 | 1.00 | CNR2 (0.53) | CNR2CNR1TRPA1TRPV1PPARA | |
| SCHEMBL10300846 | 0.98 | CNR2 (0.50) | CNR2CNR1TRPA1TRPV1PPARA | |
| SCHEMBL669178 | 0.98 | CNR2 (0.50) | CNR2CNR1TRPA1TRPV1PPARA | |
| SCHEMBL669177 | 0.98 | CNR2 (0.50) | CNR2CNR1TRPA1TRPV1PPARA | |
| SCHEMBL669179 | 0.98 | CNR2 (0.50) | CNR2CNR1TRPA1TRPV1PPARA | |
| Hydrochloric Acid SCHEMBL1875601 | 0.96 | CNR2 (0.49) | CNR2CNR1TRPA1TRPV1PPARA | |
| SCHEMBL4245971 | 0.89 | PPARA (0.60) | CNR2CNR1TRPA1TRPV1PPARA | |
| SCHEMBL8347693 | 0.89 | PPARA (0.60) | CNR2CNR1TRPA1TRPV1PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120053661-A | Hydrophilic fatty acid complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120053660-A | Hydrophilic complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119855607-A | Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application | 太阳雨林(北京)生物医药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| US-20200155575-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2020-05-21 | — | — | US | disclosed |
| US-20190269700-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2019-09-05 | — | — | US | disclosed |
| US-20180104257-A1 | (17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use | LIPOCINE INC. (US) | 2018-04-19 | — | — | US | disclosed |
| US-20180078568-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2018-03-22 | — | — | US | disclosed |
| EP-3185873-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | Lipocine Inc. (US) | 2017-07-05 | — | — | EP | disclosed |
| US-20160193225-A1 | (17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | LIPOCINE INC. (US) | 2016-07-07 | — | — | US | disclosed |
| US-20160184324-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-06-30 | — | — | US | disclosed |
| WO-2016033611-A1 | (17-β)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| WO-2016033536-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| US-8871962-B2 | Method for producing sanshool | TSUMURA & CO. (JP) | 2014-10-28 | — | — | US | disclosed |
| US-8871962-B2 | Method for producing sanshool | TSUMURA & CO. (JP) | 2014-10-28 | — | — | US | disclosed |
| US-20130245303-A1 | METHOD FOR PRODUCING SANSHOOL | TSUMURA & CO. (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20100098788-A1 | Extracts of Curcuma and Methods of Use Thereof | HERBALSCIENCE GROUP, LLC | 2010-04-22 | — | — | US | disclosed |
| WO-1999021425-A1 | TRIGEMINAL SENSORY STIMULI AND ANIMAL REPELLENTS FROM PLANTS | MONELL CHEMICAL SENSES CENTER (US) | 1999-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130245303-A1 | METHOD FOR PRODUCING SANSHOOL | SCO2, CNKSR1, FTH1 | CNR2 2612/4885CNR1 3095/4885TRPA1 4675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.